机构:[a]Ophthalmology Department, The First Affiliated Hospital of Kunming Medical University, Xichang Road 295, Kunming, Yunnan, China昆明医科大学附属第一医院[b]Ophthalmology Department, The Second Affiliated Hospital of Kunming Medical University, Dianmian Road 374, Kunming, Yunnan, China[c]Psychiatry Department, People’s Hospital of Yuxi City, Nieer Road 21, Yuxi, Yunnan, China
High-glucose induced retinal pigment epithelium (RPE) death by triggering oxidative stress, however, the underlying mechanisms are still not fully delineated. In this study, the RPE cell line ARPE-19 were treated with different concentrations of glucose, the results showed that high-glucose (50 mM) inhibited cell proliferation, promoted cell apoptosis and reactive oxygen species (ROS) production in a time-dependent manner. Notably, we found that high-glucose (50 mM) increased the expression levels of Caspase-1, Gasdermin D, NLRP3, IL-1 beta and IL-18 in ARPE-19 cells, which indicated that high-glucose triggered pyroptotic cell death. Further results validated that both ROS scavenger N-acetyl cysteine (NAC) and pyroptosis inhibitor necrosulfonamide (NSA) reversed the effects of high-glucose (50 mM) on ARPE-19 cell proliferation, apoptosis and pyroptosis. In addition, high-glucose (50 mM) significantly decreased the levels of miR-130a and superoxide dismutase (SOD) 1, and promoted tumor necrosis factor (TNF)-alpha expressions in ARPE-19 cells. Interestingly, upregulation of miR-130a increased SOD1 levels in a TNF-alpha dependent manner. Furthermore, overexpression of miR-130a abrogated the effects of high-glucose (50 mM) on the above cell functions, which were all reversed by either upregulating TNF-alpha or knocking down SOD1 in ARPE-19 cells. Taken together, upregulation of miR-130a alleviated the cytotoxic effects of high-glucose (50 mM) on ARPE-19 cells by regulating TNF-alpha/SOD1/ROS axis mediated pyroptotic cell death.
基金:
This work was supported by grants from National Natural Science
Foundation of China (No. 81060077), The Internal Research
Institutions for Scientific Research Projects of Yunnan Medical and
Health Institute (No. 2014NS183 and No. 2018NS0145), The Applied
Fundamental Research of Yunnan Province (No. 2017FE468(-175) and
No. 2017FE468(-046)) and Bethune-Lang Mu Ophthalmological
Research Fund for Middle-aged and Young Researchers (No. BJLM2017006L).
语种:
外文
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|2 区医学
小类|2 区药学3 区医学:研究与实验
最新[2023]版:
大类|2 区医学
小类|1 区药学2 区医学:研究与实验
JCR分区:
出版当年[2019]版:
Q1PHARMACOLOGY & PHARMACYQ1MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1MEDICINE, RESEARCH & EXPERIMENTALQ1PHARMACOLOGY & PHARMACY